Catalyst Wire Dossier Catalyst Wire Dossier

KAE609

cipargamin · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for KAE609, covering 2013-05-13 to 2021-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects [Phase 1]

See pricing